Category Bilateral/Regional Negotiations

European Parliament Hears Pitch For ACTA; But Did It Change Minds?

The controversial Anti-Counterfeiting Trade Agreement consumed hours of European Parliament time this week as the European Commission sought to persuade lawmakers to approve it. But no matter how often EC officials, academics and lawyers said the treaty will not change EU law, scepticism still remains about its potential impact on digital freedoms and access to generic medicines in developing countries – including from the Parliament member who will author the legislative report.

Most-Read IP-Watch Posts Of 2011 Tell Story Of International IP Policymaking

The most-read Intellectual Property Watch stories of 2011 demonstrated the versatility and range of our readers from around the globe, from an intense focus on international and national copyright issues to bilateral and plurilateral free trade agreements, to issues in India and Brazil, patent laws, patents in agriculture, scientific knowledge, and of course, policies emerging in Geneva at the World Intellectual Property Organization, World Trade Organization, World Health Organization and elsewhere at the multilateral level. Most of all, they tell the story of the year gone by, with clear signals of what's to come in 2012.

Special Report – US IP Attachés Report On Strategies Abroad

WASHINGTON, DC - American intellectual property attachés serving abroad have helped propel global discussions on intellectual property rights and have helped protect inventors’ rights amidst a “global flat economy,” but enforcement remains a difficult challenge in many parts of the world, attachés said at a recent event gathering them back home. The officials highlighted strategies for the coming year in the top emerging economies.

WTO IP Committee Addresses Medicines Access, Plain-Packaged Tobacco, ACTA

The World Trade Organization committee responsible for intellectual property rights issues is meeting this week and will address several items of potential debate, including a nearly unused 2003 provision for compulsory-licensed medicines exports to poor countries, a WTO member’s attempt to discourage smoking through unlabelled tobacco packaging, and IP enforcement raised by a small but potent group of WTO members who negotiated the Anti-Counterfeiting Trade Agreement (ACTA).